Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)
NCT00480194 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2012-05-07
Summary
The objectives of the study are to obtain knowledge about the safety in use, the patients' general impression of the treatment and the pattern of use of ZyComb® in an over-the-counter (OTC) setting.
Conditions
- Common Cold
Interventions
- DRUG
-
xylometazoline hydrochloride and ipratropium bromide (ZyComb)
Common cold in a real-life OTC setting
Sponsors & Collaborators
-
Nycomed
lead INDUSTRY
Principal Investigators
-
Nycomed Clinical Trial Operations · Headquaters
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2008-01-31
- Completion
- 2008-01-31
More Related Trials
-
Nasal Prep for Nasendoscopy in Children
NCT01351298 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.
NCT03439436 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Two Nasal Products Based on Diluted Seawater in the Treatment of Upper Respiratory Infections/Conditions
NCT06498843 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of Two Nasal Products for Decongestion and Mucus Fluidification
NCT04230993 ·Status: COMPLETED ·Phase: NA
-
A Study of an Experimental Nasal Spray in Subjects With Early Signs of the Common Cold
NCT01488604 ·Status: COMPLETED ·Phase: NA
-
Nasal Decongestion and Obstructive Sleep Apnea
NCT00630474 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage
NCT05126407 ·Status: COMPLETED
-
Xylitol for Otitis Media
NCT02950311 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Otrivine: Quality of Life (QoL) Impact in a Real-World Setting
NCT05556148 ·Status: COMPLETED ·Phase: PHASE4
-
Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer® Antiseptic
NCT01861457 ·Status: COMPLETED ·Phase: NA
-
Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
NCT05542095 ·Status: WITHDRAWN ·Phase: PHASE1
-
Intranasal Lavage With Hypochlorous Acid Safely Reduces the Symptoms in the Ambulatory Patient With COVID-19.
NCT05950295 ·Status: COMPLETED
-
Immediate Effect of Proponent-Nasal-Spray on Unspecific Discomfort in the Nose
NCT03251066 ·Status: COMPLETED ·Phase: NA
-
Treatment of Acute Sinusitis
NCT00377403 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.
NCT04951349 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Efficacy of a SinuSonic Intervention
NCT03906968 ·Status: COMPLETED ·Phase: NA
-
Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants
NCT02832362 ·Status: COMPLETED ·Phase: PHASE1
-
Maxillary Sinus Irrigation in the Management of Chronic Rhinosinusitis
NCT00335309 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Tolerability of Intranasal LMN-301
NCT06030414 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study
NCT01364467 ·Status: COMPLETED ·Phase: PHASE2
-
Xylitol Based Nasal Spray for COVID-19 Treatment
NCT05618483 ·Status: UNKNOWN ·Phase: NA
-
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
NCT06076304 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Pharmacokinetic Study of Intranasal 2-DG in Healthy Volunteers
NCT05314933 ·Status: COMPLETED ·Phase: PHASE1
-
A Nasal Spray With Glucose Oxidase as a Treatment of Common Cold
NCT01883453 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial.
NCT02285634 ·Status: COMPLETED ·Phase: NA